Kortright, Ok. E., Chan, B. Ok., Koff, J. L. & Turner, P. E. Phage remedy: a renewed method to fight antibiotic-resistant micro organism. Cell Host Microbe 25, 219–232 (2019).
Pires, D. P., Cleto, S., Sillankorva, S., Azeredo, J. & Lu, T. Ok. Genetically engineered phages: a evaluation of advances during the last decade. Microbiol. Mol. Biol. Rev. 80, 523–543 (2016).
Doss, J., Culbertson, Ok., Hahn, D., Camacho, J. & Barekzi, N. A evaluation of phage remedy towards bacterial pathogens of aquatic and terrestrial organisms.Viruses 9, 50 (2017).
Nobrega, F. L., Costa, A. R., Kluskens, L. D. & Azeredo, J. Revisiting phage remedy: new functions for previous assets. Traits Microbiol. 23, 185–191 (2015).
Łusiak-Szelachowska, M. et al. Phage neutralization by sera of sufferers receiving phage remedy. Viral Immunol. 27, 295–304 (2014).
Weber-Dąbrowska, B. et al. Bacteriophage procurement for therapeutic functions. Entrance. Microbiol. 7, 1177 (2016).
Lu, T. Ok. & Koeris, M. S. The subsequent era of bacteriophage remedy. Curr. Opin. Microbiol. 14, 524–531 (2011).
Lenneman, B. R., Fernbach, J., Loessner, M. J., Lu, T. Ok. & Kilcher, S. Enhancing phage remedy by way of artificial biology and genome engineering. Curr. Opin. Biotechnol. 68, 151–159 (2021).
Ando, H., Lemire, S., Pires, D. P. & Lu, T. Ok. Engineering modular viral scaffolds for focused bacterial inhabitants enhancing. Cell Syst. 1, 187–196 (2015).
Mahichi, F., Synnott, A. J., Yamamichi, Ok., Osada, T. & Tanji, Y. Web site-specific recombination of T2 phage utilizing IP008 lengthy tail fiber genes offers a focused methodology for increasing host vary whereas retaining lytic exercise. FEMS Microbiol. Lett. 295, 211–217 (2009).
Matsuda, T. et al. Lysis-deficient bacteriophage remedy decreases endotoxin and inflammatory mediator launch and improves survival in a murine peritonitis mannequin. Surgical procedure 137, 639–646 (2005).
Monteiro, R., Pires, D. P., Costa, A. R. & Azeredo, J. Phage remedy: going temperate? Traits Microbiol. 27, 368–378 (2019).
Kilcher, S. & Loessner, M. J. Engineering bacteriophages as versatile biologics. Traits Microbiol. 27, 355–367 (2019).
Marinelli, L. J., Hatfull, G. F. & Piuri, M. Recombineering: a strong software for modification of bacteriophage genomes. Bacteriophage 2, 5–14 (2012).
Deveau, H., Garneau, J. E. & Moineau, S. CRISPR/Cas system and its function in phage-bacteria interactions. Annu. Rev. Microbiol. 64, 475–493 (2010).
Hille, F. et al. The Biology of CRISPR–Cas: back and forth. Cell 172, 1239–1259 (2018).
Mayo-Muñoz, D. et al. Anti-CRISPR-based and CRISPR-based genome enhancing of Sulfolobus islandicus rod-shaped virus 2.Viruses 10, 695 (2018).
Samson, J. E., Magadan, A. H., Sabri, M. & Moineau, S. Revenge of the phages: defeating bacterial defences. Nat. Rev. Microbiol. 11, 675–687 (2013).
Malone, L. M., Birkholz, N. & Fineran, P. C. Conquering CRISPR: how phages overcome bacterial adaptive immunity. Curr. Opin. Biotechnol. 68, 30–36 (2021).
Mendoza, S. D. et al. A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases. Nature 577, 244–248 (2020).
Malone, L. M. et al. A jumbo phage that varieties a nucleus-like construction evades CRISPR–Cas DNA focusing on however is weak to sort III RNA-based immunity. Nat. Microbiol. 5, 48–55 (2020).
Guan, J. & Bondy-Denomy, J.Intracellular group by jumbo bacteriophages.J. Bacteriol. 203, e00362-20 (2020).
Abudayyeh, O. O. et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353, aaf5573 (2016).
Meeske, A. J., Nakandakari-Higa, S. & Marraffini, L. A. Cas13-induced mobile dormancy prevents the rise of CRISPR-resistant bacteriophage. Nature 570, 241–245 (2019).
Meeske, A. J. et al. A phage-encoded anti-CRISPR permits full evasion of sort VI-A CRISPR–Cas immunity. Science 369, 54–59 (2020).
East-Seletsky, A. et al. Two distinct RNase actions of CRISPR–C2c2 allow guide-RNA processing and RNA detection. Nature 538, 270–273 (2016).
Meeske, A. J. & Marraffini, L. A. RNA information complementarity prevents self-targeting in sort VI CRISPR programs. Mol. Cell 71, 791–801.e3 (2018).
M Iyer, L., Anantharaman, V., Krishnan, A., Maxwell Burroughs, A. & Aravind, L. Jumbo phages: a comparative genomic overview of core features and adaptions for organic conflicts.Viruses 13, 63 (2021).
Al-Shayeb, B. et al. Clades of giant phages from throughout Earth’s ecosystems. Nature 578, 425–431 (2020).
Aylett, C. H. S., Izoré, T., Amos, L. A. & Löwe, J. Construction of the tubulin/FtsZ-like protein TubZ from Pseudomonas bacteriophage ΦKZ. J. Mol. Biol. 425, 2164–2173 (2013).
Chaikeeratisak, V. et al. The phage nucleus and tubulin spindle are conserved amongst giant Pseudomonas phages. Cell Rep. 20, 1563–1571 (2017).
Chaikeeratisak, V. et al. Viral capsid trafficking alongside treadmilling tubulin filaments in micro organism. Cell 177, 1771–1780.e12 (2019).
Kraemer, J. A. et al. A phage tubulin assembles dynamic filaments by an atypical mechanism to middle viral DNA inside the host cell. Cell 149, 1488–1499 (2012).
Chaikeeratisak, V. et al. Meeting of a nucleus-like construction throughout viral replication in micro organism. Science 355, 194–197 (2017).
Wu, W., Thomas, J. A., Cheng, N., Black, L. W. & Steven, A. C. Bubblegrams reveal the inside physique of bacteriophage ΦKZ. Science 335, 182 (2012).
Thomas, J. A. et al. Intensive proteolysis of head and inside physique proteins by a morphogenetic protease within the large Pseudomonas aeruginosa phage ΦKZ. Mol. Microbiol. 84, 324–339 (2012).
Chan, B. Ok. et al. Phage choice restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci. Rep. 6, 26717 (2016).
Chan, B. Ok. et al. Phage remedy of an aortic graft contaminated with Pseudomonas aeruginosa. Evol. Med. Public Well being 2018, 60–66 (2018).
Sepúlveda-Robles, O., Kameyama, L. & Guarneros, G. Excessive range and novel species of Pseudomonas aeruginosa bacteriophages. Appl. Environ. Microbiol. 78, 4510–4515 (2012).
Cruz-Plancarte, I., Cazares, A. & Guarneros, G. Genomic and transcriptional mapping of PaMx41, archetype of a brand new lineage of bacteriophages infecting Pseudomonas aeruginosa. Appl. Environ. Microbiol. 82, 6541–6547 (2016).
Huiting, E. et al. Bacteriophages antagonize cGAS-like immunity in micro organism. Preprint at bioRxiv https://doi.org/10.1101/2022.03.30.486325 (2022).
Skennerton, C. T. et al. Phage encoded H-NS: a possible Achilles heel within the bacterial defence system. PLoS ONE 6, e20095 (2011).
Pul, U. et al. Identification and characterization of E. coli CRISPR–cas promoters and their silencing by H-NS. Mol. Microbiol. 75, 1495–1512 (2010).
Hampton, H. G., Watson, B. N. J. & Fineran, P. C. The arms race between micro organism and their phage foes. Nature 577, 327–336 (2020).
Vlot, M. et al. Bacteriophage DNA glucosylation impairs goal DNA binding by sort I and II however not by sort V CRISPR–Cas effector complexes. Nucleic Acids Res. 46, 873–885 (2018).
Bryson, A. L. et al. Covalent modification of bacteriophage T4 DNA inhibits CRISPR–Cas9. mBio 6, e00648 (2015).
Liu, Y. et al. Covalent modifications of the bacteriophage genome confer a level of resistance to bacterial CRISPR programs.J. Virol. 94, e01630-20 (2020).
Davidson, A. R. et al. Anti-CRISPRs: protein inhibitors of CRISPR–Cas programs. Annu. Rev. Biochem. 89, 309–332 (2020).
Makarova, Ok. S. et al. Evolutionary classification of CRISPR–Cas programs: a burst of sophistication 2 and derived variants. Nat. Rev. Microbiol. 18, 67–83 (2020).
Adler, B. et al. RNA-targeting CRISPR–Cas13 offers broad-spectrum phage immunity. Preprint at bioRxiv https://doi.org/10.1101/2022.03.25.485874 (2022).
Krylov, V. N. et al. Pseudomonas bacteriophage ΦKZ incorporates an inside physique in its capsid. Can. J. Microbiol. 30, 758–762 (1984).
van Beljouw, S. P. B. et al. The gRAMP CRISPR–Cas effector is an RNA endonuclease complexed with a caspase-like peptidase. Science 373, 1349–1353 (2021).
Özcan, A. et al. Programmable RNA focusing on with the single-protein CRISPR effector Cas7-11. Nature 597, 720–725 (2021).
